Hangzhou Leap Chem Co., Ltd. yog ib qho ntawm cov kws tshaj lij thiab cov neeg muag khoom ntawm ruxolitinib phosphate 丨cas 1092939-17-7 hauv Suav teb. Txais tos rau kev lag luam wholesale kev cai ua cov khoom lag luam ntawm tus nqi sib tw los ntawm peb lub hoobkas. Rau cov khoom pheej yig dua, tiv tauj peb tam sim no.
Specifications
| Qhov tshwm sim | Tawm dawb los yog hmoov dawb |
| Purity (HPLC) | 99% min. |
| Kev txheeb xyuas los ntawm NMR | Ua raws li kev siv spectrum |
| Kev txheeb xyuas los ntawm IR | Kev nqus IR ntawm cov qauv yuav tsum ua raws li Cov Qauv Ntsuas |
| Residue ntawm ignition | 0.2% max. |
| Dej los ntawm KF | 1% max. |
Daim ntawv thov
Ruxolitinib Phosphate feem ntau yog siv hauv kev lag luam kws tshuaj raws li lub zog Janus kinase (JAK) inhibitor. Nws yog siv rau hauv kev kho mob ntawm myeloproliferative mob xws li myelofibrosis thiab polycythemia vera, qhov twg dysregulated JAK-STAT signaling drives txawv txav cell proliferation. Cov tshuaj tseem raug tshawb xyuas hauv kev tshawb fawb rau lwm yam mob thiab autoimmune mob, suav nrog graft- tiv thaiv -tus kab mob thiab qee yam kab mob dermatological, vim nws cov khoom tiv thaiv kab mob. Hauv kev tsim tshuaj, Ruxolitinib Phosphate yog siv los ua tus qauv JAK inhibitor rau kev kawm kinase signaling pathways, optimizing pharmacokinetics, thiab tsim cov formulations tshiab rau qhov ncauj los yog tshuaj pleev.
Cov txiaj ntsig
Ruxolitinib Phosphate muaj ntau yam zoo hauv kev kho mob thiab kev tshawb fawb siv. Nws cov kev xaiv inhibition ntawm JAK1 thiab JAK2 kinases muab lub hom phiaj kev hloov pauv ntawm cytokine signaling txoj hauv kev, txo qis cov cell proliferation thiab o nrog kev tswj tshwj xeeb. Daim ntawv ntsev phosphate txhim kho dej solubility thiab bioavailability, yooj yim formulation rau hauv qhov ncauj los yog txhaj tshuaj npaj. Qhov sib xyaw ua ke tau pom tias muaj txiaj ntsig zoo hauv kev tshawb fawb soj ntsuam txhawm rau txhim kho cov tsos mob, txo tus po loj, thiab txhim kho lub neej zoo hauv cov neeg mob uas muaj kab mob myeloproliferative. Nws zoo -tus yam ntxwv pharmacological profile thiab kev rov ua dua tshiab txhawb nqa ob qho tib si kev kho mob thiab kev tshawb fawb hauv preclinical hauv kinase inhibition thiab kev tiv thaiv kab mob.
Xaus
Ruxolitinib Phosphate yog ib qho kev xaiv JAK inhibitor nrog kev siv hauv kev kho mob myeloproliferative thiab autoimmune mob, nrog rau kev tshawb fawb ntawm kinase signaling. Nws lub hom phiaj kev ua ub no, solubility, thiab kev siv tshuaj kho mob ua rau nws muaj txiaj ntsig hauv ob qho tib si kho mob thiab kev txhim kho tshuaj. Zuag qhia tag nrho, Ruxolitinib Phosphate txhawb kev hloov kho ntawm JAK-STAT txoj hauv kev, txhim kho cov txiaj ntsig ntawm tus neeg mob thiab nce qib kev tshawb fawb tshuaj.
Cim npe nrov: ruxolitinib phosphate 丨cas 1092939-17-7, Tuam Tshoj ruxolitinib phosphate 丨cas 1092939-17-7 manufacturers, lwm tus, Hoobkas

